Advertisement
DYN Новости Форекс
Dyne Therapeutics Announces Positive Initial Clinical Data From ACHIEVE And DELIVER Trials
Muscle disease company Dyne Therapeutics, Inc. (DYN) announced Wednesday positive initial clinical data from its ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1) and its DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.
RTTNews
|
586 дней спустя
